Jay Brad­ner joins Am­gen to lead R&D as David Reese moves to new chief tech­nol­o­gy of­fi­cer role

Am­gen is mak­ing a ma­jor ad­di­tion to its re­search lead­er­ship, bring­ing for­mer No­var­tis re­search ex­ec­u­tive Jay Brad­ner in­to a top role while shift­ing cur­rent R&D chief David Reese to lead tech­nol­o­gy and AI.

Brad­ner left his role last year as head of No­var­tis’ re­search arm, the No­var­tis In­sti­tutes for Bio­Med­ical Re­search, fol­low­ing a ma­jor shake­up at the phar­ma com­pa­ny. He was suc­ceed­ed by Fiona Mar­shall, who was pre­vi­ous­ly Mer­ck’s dis­cov­ery and trans­la­tion­al med­i­cine head. For a year, Brad­ner re­turned to be­ing a clin­i­cian at the Dana-Far­ber Can­cer In­sti­tute and Brigham & Women’s Hos­pi­tal. Be­fore join­ing No­var­tis near­ly eight years ago, Brad­ner had been a well-known physi­cian-sci­en­tist at Dana-Far­ber and Har­vard Med­ical School.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER